Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Pfizer Inc. et al v. Aurobindo Pharma Limited et al
Case Number:
1:11-cv-00569
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
November 07, 2011
Pfizer, Aurobindo Reach Accord In Lipitor Patent Case
Pfizer Inc. and Aurobindo Pharma Ltd. reached a settlement agreement Monday that wraps up a patent infringement case Pfizer brought over Aurobindo's efforts to horn in on the market for its blockbuster cholesterol drug Lipitor.
-
June 28, 2011
Pfizer Fights Aurobindo's Bid To Sell Generic Lipitor
Pfizer Inc. struck Aurobindo Pharma Ltd. with a suit in Delaware on Monday seeking to block the generic-drug maker's version of Lipitor, continuing its ongoing battle to maintain exclusive rights to sell the cholesterol-lowering drug.